Mind of the Resuscitationist Episode on Functional Heuristics
A different take on IV T3 for Myxedema
The RECOVERY trial just released a preprint demonstrating benefit from tocilizumab in COVID-19. As with the prior RECOVERY studies, this is a multicenter, open-label, pragmatic trial. A robust mortality benefit was detected (the fragility index calculates to 17, which isn’t too shabby). Several important secondary endpoints were positive as well (e.g., reduced intubation rate, reduced […]
Ketamine IS AT LEAST as hemodynamically stable as ETOMIDATE!!!
Thyroid storm’s boring brother is still a life threat–you need to know it!